Maher Albitar, Chief Medical Officer at NEOGENOMICS INC (NEO), sold 2,800 shares at $8.40 ($24K) on 2016-09-23, disclosed to the SEC on 2016-09-27.
Open-market sale of $24k NEO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NEO | SELL | 2016-08-23 | $3.0M | — | Filing → |
| NEO | BUY | 2014-03-31 | $51K | — | Filing → |